Background: Since October 2018, lymph node status has become part of the FIGO staging, given that it is one of the most important prognostic factors among women with CC. The aim was to determine the rate of atypical lymphatic drainage in patients with clinical early-stage cervical cancer using a hybrid tracer (ICG-Tc nanocolloid).
Methodology: A prospective, observational, single-centre study conducted at Son Espases University Hospital between January 2019 and October 2023.